<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'><collection><source>PubTator</source><date></date><key>BioC.key</key><document><id>31221853</id><passage><infon key="journal">Science. 2019 Jun 21;364(6446):1156-1162. doi: 10.1126/science.aaw3145.</infon><infon key="year">2019</infon><infon key="article-id_pmc">PMC6705393</infon><infon key="type">title</infon><infon key="authors">Engle DD, Tiriac H, Rivera KD, Pommier A, Whalen S, Oni TE, Alagesan B, Lee EJ, Yao MA, Lucito MS, Spielman B, Da Silva B, Schoepfer C, Wright K, Creighton B, Afinowicz L, Yu KH, Grutzmann R, Aust D, Gimotty PA, Pollard KS, Hruban RH, Goggins MG, Pilarsky C, Park Y, Pappin DJ, Hollingsworth MA, Tuveson DA</infon><offset>0</offset><text>The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice.</text><annotation id="4"><infon key="identifier">MESH:D011134</infon><infon key="type">Chemical</infon><location offset="4" length="6" /><text>glycan</text></annotation><annotation id="5"><infon key="identifier">MESH:D010195</infon><infon key="type">Disease</infon><location offset="27" length="12" /><text>pancreatitis</text></annotation><annotation id="6"><infon key="identifier">MESH:D010190</infon><infon key="type">Disease</infon><location offset="44" length="17" /><text>pancreatic cancer</text></annotation><annotation id="7"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="65" length="4" /><text>mice</text></annotation></passage><passage><infon key="type">abstract</infon><offset>71</offset><text>Glycosylation alterations are indicative of tissue inflammation and neoplasia, but whether these alterations contribute to disease pathogenesis is largely unknown. To study the role of glycan changes in pancreatic disease, we inducibly expressed human fucosyltransferase 3 and beta1,3-galactosyltransferase 5 in mice, reconstituting the glycan sialyl-Lewisa, also known as carbohydrate antigen 19-9 (CA19-9). Notably, CA19-9 expression in mice resulted in rapid and severe pancreatitis with hyperactivation of epidermal growth factor receptor (EGFR) signaling. Mechanistically, CA19-9 modification of the matricellular protein fibulin-3 increased its interaction with EGFR, and blockade of fibulin-3, EGFR ligands, or CA19-9 prevented EGFR hyperactivation in organoids. CA19-9-mediated pancreatitis was reversible and could be suppressed with CA19-9 antibodies. CA19-9 also cooperated with the KrasG12D oncogene to produce aggressive pancreatic cancer. These findings implicate CA19-9 in the etiology of pancreatitis and pancreatic cancer and nominate CA19-9 as a therapeutic target.</text><annotation id="29"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="122" length="12" /><text>inflammation</text></annotation><annotation id="30"><infon key="identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="139" length="9" /><text>neoplasia</text></annotation><annotation id="31"><infon key="identifier">MESH:D011134</infon><infon key="type">Chemical</infon><location offset="256" length="6" /><text>glycan</text></annotation><annotation id="32"><infon key="identifier">MESH:D010182</infon><infon key="type">Disease</infon><location offset="274" length="18" /><text>pancreatic disease</text></annotation><annotation id="33"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="317" length="5" /><text>human</text></annotation><annotation id="34"><infon key="identifier">10317</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">13230</infon><location offset="348" length="31" /><text>beta1,3-galactosyltransferase 5</text></annotation><annotation id="35"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="383" length="4" /><text>mice</text></annotation><annotation id="36"><infon key="identifier">MESH:D011134</infon><infon key="type">Chemical</infon><location offset="408" length="6" /><text>glycan</text></annotation><annotation id="37"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="510" length="4" /><text>mice</text></annotation><annotation id="38"><infon key="identifier">MESH:D010195</infon><infon key="type">Disease</infon><location offset="544" length="12" /><text>pancreatitis</text></annotation><annotation id="39"><infon key="identifier">13649</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">74545</infon><location offset="581" length="32" /><text>epidermal growth factor receptor</text></annotation><annotation id="40"><infon key="identifier">13649</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">74545</infon><location offset="615" length="4" /><text>EGFR</text></annotation><annotation id="41"><infon key="identifier">216616</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">3028</infon><location offset="698" length="9" /><text>fibulin-3</text></annotation><annotation id="42"><infon key="identifier">13649</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">74545</infon><location offset="739" length="4" /><text>EGFR</text></annotation><annotation id="43"><infon key="identifier">216616</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">3028</infon><location offset="761" length="9" /><text>fibulin-3</text></annotation><annotation id="44"><infon key="identifier">13649</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">74545</infon><location offset="772" length="4" /><text>EGFR</text></annotation><annotation id="45"><infon key="identifier">13649</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">74545</infon><location offset="806" length="4" /><text>EGFR</text></annotation><annotation id="46"><infon key="identifier">MESH:D010195</infon><infon key="type">Disease</infon><location offset="857" length="12" /><text>pancreatitis</text></annotation><annotation id="47"><infon key="identifier">MESH:D010190</infon><infon key="type">Disease</infon><location offset="1005" length="17" /><text>pancreatic cancer</text></annotation><annotation id="48"><infon key="identifier">MESH:D010195</infon><infon key="type">Disease</infon><location offset="1075" length="12" /><text>pancreatitis</text></annotation><annotation id="49"><infon key="identifier">MESH:D010190</infon><infon key="type">Disease</infon><location offset="1092" length="17" /><text>pancreatic cancer</text></annotation></passage><relation id="R1"><infon key="score">0.9983</infon><infon key="role1">Chemical|MESH:D011134</infon><infon key="role2">Disease|MESH:D010182</infon><infon key="type">Association</infon><node refid="0" role="6,7" /></relation><relation id="R2"><infon key="score">0.6732</infon><infon key="role1">Chemical|MESH:D011134</infon><infon key="role2">Disease|MESH:D010195</infon><infon key="type">Association</infon><node refid="1" role="0,1" /></relation><relation id="R3"><infon key="score">0.986</infon><infon key="role1">Disease|MESH:D010195</infon><infon key="role2">Gene|13649</infon><infon key="type">Association</infon><node refid="2" role="13,14" /></relation><relation id="R4"><infon key="score">0.8971</infon><infon key="role1">Gene|13649</infon><infon key="role2">Gene|216616</infon><infon key="type">Association</infon><node refid="3" role="17,16" /></relation><relation id="R5"><infon key="score">0.9128</infon><infon key="role1">Chemical|MESH:D011134</infon><infon key="role2">Disease|MESH:D010190</infon><infon key="type">Association</infon><node refid="4" role="0,2" /></relation></document></collection>